| |
|
|
The genus Clostridium represents a large number of species
of anaerobic spore-forming bacteria. TetraVitae has patented
a mutant strain of Clostridium beijerinckii that produces
higher levels of butanol than wild-type strains and that is
known for its stability, robustness, and responsiveness to
genetic modification and improvement.
Tetravitae Bioscience has patented
a mutant strain of C. beijerinckii (a species of rod-shaped
anaerobic bacteria known for their synthesis of organic solvents)
that selectively produces high levels of butanol relative
to any other known strain and that is known for its stability,
robustness, continuous processes adaptability, and responsiveness
to genetic modification and improvement. Results from the
current bench-scale integrated process demonstrated significant
improvements in final solvent concentration, yield, and productivity
over batch production methodologies.
Specific attributes and advantages of TetraVitae’s microorganism
platform include:
|
|
High yield on feedstock,
which results in lower feedstock costs |
|
|
High final product concentration / reduced
Product inhibition |
|
|
High selectivity to butanol production |
|
|
Ability to effectively use low-cost cellulosic
feedstocks |
An additional advantage of C. beijerinckii is the fact that
the solvent producing genes are located on the chromosome
(rather than on the plasmid for some other species). This
has the effect of making C. beijerinckii more genetically
stable – an important requirement of a commercial deployment.
TetraVitae is actively developing enhanced
strains, more efficient process engineering, and the ability
to use low-cost feedstocks. These efforts will contribute
to significant additional production cost reductions.
|
|